Summary
The influence of blockade or stimulation of dopamine (DA) receptors on the selective increase in brain DA seen after axotomy or injection of gammahydroxybutyric acid (sodium form, 1.5 g/kg i.p.) was studied in rats. The increases were not changed after blockade of the DA receptors by haloperidol but were slightly reduced after stimulation of these receptors by apomorphine. Since pretreatment with haloperidol counteracted this effect of apomorphine, a diminished stimulation of DA receptors may partially be responsible for the increase in brain DA seen when the nerve impulse flow has been blocked in the DA neurones by axotomy or treatment with gammahydroxybutyric acid. The NA content was usually somewhat lowered on the lesioned side and this reduction was not changed after treatment with haloperidol, apomorphine or amphetamine.
The increase in brain DA usually observed after axotomy was not found when the rats were also treated with reserpine and nialamide. This effect indicates that the negative feed-back of cytoplasmic DA on the DA synthesis operates also in the absence of nerve impulses.
Injection of amphetamine before or after axotomy or treatment with gammahydroxybytyric acid markedly inhibited the increase in brain DA, probably due to release of newly synthesized DA.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alousi, A., Weiner, N.: The regulation of norepinephrine synthesis in sympathetic nerves: effect of nerve stimulation, cocaine, and catecholamine-releasing agents. Proc. nat. Acad. Sci. (Wash.) 56, 1491–1496 (1966).
Andén, N.-E.: Effects of amphetamine and some other drugs on central catecholamine mechanisms. In: E. Costa and S. Garattini: Amphetamines and related compounds, pp. 447–462. New York: Raven Press 1970.
Andén, N.-E., Bédard, P., Fuxe, K., Ungerstedt, U.: Early and selective increase in brain dopamine levels after axotomy. Experientia (Basel) 28, 300–301 (1972).
Andén, N.-E., Carlsson, A., Häggendal, J.: Adrenergic mechanisms. Ann. Rev. Pharmacol. 9, 119–134 (1969).
Andén, N.-E., Corrodi, H., Fuxe, K., Ungerstedt, U.: Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons. Europ. J. Pharmacol. 15, 193–199 (1971).
Andén, N.-E., Dahlström, A., Fuxe, K., Larsson, K.: Functional role of the nigroneostriatal dopamine neurons. Acta pharmacol. (Kbh.) 24, 263–274 (1966).
Andén, N.-E., Magnusson, T.: Influences of drugs on the increases in brain dopamine produced by axotomy or gammahydroxybutyric acid. Acta pharmacol. (Kbh.) 31, Suppl. I, 27 (1972).
Andén, N.-E., Rubenson, A., Fuxe, K., Hökfelt, T.: Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol. 19, 627–629 (1967).
Carlsson, A.: Amphetamine and brain catecholamines. In: E. Costa and S. Garattini: Amphetamines and related compounds, pp. 289–300. New York: Raven Press 1970.
Carlsson, A., Kehr, W., Lindqvist, M., Magnusson, T., Atack, C. V.: Regulation of monoamine metabolism in the central nervous system. Pharmacol. Rev. 24, 371–384 (1972).
Carlsson, A., Lindqvist, M., Magnusson, T.: On the biochemistry and possible functions of dopamine and noradrenaline in brain. In: J. R. Vane, G. E. W. Wolstenholme, and M. O'Connor: Adrenergic mechanisms, pp. 432–439. London: Churchill 1960.
Ernst, A. M.: Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia (Berl.) 10, 316–323 (1967).
Gessa, G. L., Vargiu, L., Crabai, F., Boero, G. C., Caboni, F., Camba, R.: Selective increase of brain dopamine induced by gamma-hydroxybutyrate. Life Sci. 5, 1921–1930 (1966).
Goldstein, M., Freedman, L. S., Backstrom, T.: The inhibition of catecholamine biosynthesis by apomorphine. J. Pharm. Pharmacol. 22, 715–717 (1970).
Hutchins, D. A., Rayevsky, K. S., Sharman, D. F.: The effect of sodium γ-hydroxybutyrate on the metabolism of dopamine in the brain. Brit. J. Pharmacol. 46, 409–415 (1972).
Javoy, F., Agid, Y., Bouvet, D., Glowinski, J.: Feedback control of dopamine synthesis in dopaminergic terminals of the rat striatum. J. Pharmacol. exp. Ther. 182, 454–463 (1972).
Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., Atack, C.: Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. J. Pharm. Pharmacol. 24, 744–747 (1972).
Neff, N. H., Costa, E.: Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration. J. Pharmacol. exp. Ther. 160, 40–47 (1968).
Spector, S., Gordon, R., Sjoerdsma, A., Udenfriend, S.: End-product inhibition of tyrosine hydroxylase as a possible mechanism for regulation of norepinephrine synthesis. Molec. Pharmacol. 3, 549–555 (1967).
Stock, G., Magnusson, T., Andén, N.-E.: Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 347–361 (1973).
Sulser, F., Sanders-Bush, E.: Effect of drugs on amines in the CNS. Ann. Rev. Pharmacol. 11, 109–230 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andén, NE., Magnusson, T. & Stock, G. Effects of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gammahydroxybutyric acid. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 363–372 (1973). https://doi.org/10.1007/BF00501480
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00501480